Skip to main content
RKLBFYI

Intelligence Hub

Market analytics and operational performance indicators

Last Updated: 49 minutes ago
Back to Filings
FORM 144
AI

144 - March 2, 2026

Filed March 2, 2026
·
0002001011-26-000014

Rocket Lab CEO Peter Beck files Form 144 to sell 18,857 shares ($1.3M) for RSU tax coverage.

Brief

This Form 144 filing by Peter Beck, Rocket Lab's CEO and Director, discloses the proposed sale of 18,857 common shares on March 2, 2026. The sales, totaling approximately $1.31 million, are to satisfy tax obligations from the vesting of 47,745 restricted stock units on March 1, 2026. It is a routine insider transaction with no sales reported in the prior three months.

Detailed Brief

Form 144 is a notice of proposed sale of restricted securities under Rule 144, filed by Peter Beck, who is listed as a Director of Rocket Lab USA Inc. (though publicly known as CEO and founder). On March 1, 2026, 39,469 and 8,276 restricted stock units vested as compensation from the issuer, totaling 47,745 shares. Beck plans to sell 3,269 shares (value $227,489.30) and 15,588 shares (value $1,084,766.99) via Morgan Stanley on March 2, 2026, at an implied price of ~$69.60 per share, with 567,445,449 shares outstanding. The remarks specify the sale covers tax obligations from the vested equity award settlement. Beck certifies no knowledge of undisclosed material adverse information regarding Rocket Lab's operations. No securities were sold by Beck in the past three months.

Key Telemetry

  • Peter Beck (CEO/Director) to sell 18,857 common shares (3,269 + 15,588) on 03/02/2026 via Morgan Stanley.
  • Total aggregate market value: $1,312,256.29 (~$69.60/share).
  • Shares from vesting of 47,745 RSUs (39,469 + 8,276) on 03/01/2026 as compensation.
  • No insider sales by Beck in past 3 months; sale solely to cover taxes on vesting.
  • Certifies no undisclosed material adverse information.

Impact Vector

This is a standard 'sell-to-cover' transaction for executives to pay taxes on vesting equity awards, representing a tiny fraction (<0.004%) of outstanding shares and not indicative of reduced confidence in Rocket Lab. It highlights ongoing equity compensation aligning management with shareholders amid the company's growth in launch services and space systems. Investors should monitor future Form 4 filings for net share retention and any open-market sales, but this filing poses no near-term concerns.

Search
Search across missions, customers, news, and SEC filings